• Explore /
  • Poster
  • / A phase I study of carboplatin and talazoparib in patients with and without DNA repair mutations.

A phase I study of carboplatin and talazoparib in patients with and without DNA repair mutations.

Abstract Poster

Authors

null

Mallika Sachdev Dhawan

University of California, San Francisco, San Francisco, CA

Mallika Sachdev Dhawan , Imke Heleen Bartelink , Rahul Raj Aggarwal , Jim Leng , Robin Kate Kelley , Michelle E. Melisko , Charles J. Ryan , Scott Thomas , Pamela N. Munster

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2017 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Developmental Therapeutics—Clinical Pharmacology and Experimental Therapeutics

Track

Developmental Therapeutics and Translational Research

Sub Track

Chemotherapy

Clinical Trial Registration Number

NCT02317874

Citation

J Clin Oncol 35, 2017 (suppl; abstr 2527)

DOI

10.1200/JCO.2017.35.15_suppl.2527

Abstract #

2527

Poster Bd #

19

Abstract Disclosures

Similar Posters

First Author: Mallika Sachdev Dhawan

First Author: Junning Cao

First Author: Taofeek Kunle Owonikoko

First Author: Sara Michele Federico